Search research articles
Contact Us
Filters
Showing results (471-480 of 488) with videos related to
Page
of 49
Sort By:
Plos Medicine
|
September 24, 2014
Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial
Raquel González, Ghyslain Mombo-Ngoma, Smaïla Ouédraogo, et al.
Antimicrobial Agents and Chemotherapy
|
June 12, 2026
Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV
Linda Stöger, Johannes Mischlinger, Tacilta Nhampossa, et al.
Science Advances
|
January 15, 2025
CD4<sup>+</sup>FOXP3Exon2<sup>+</sup> regulatory T cell frequency predicts breast cancer prognosis and survival
Clorinda Fusco, Francesca Di Rella, Antonietta Liotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial
F Perrone, F Nuzzo, F Di Rella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2012
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study
F Nuzzo, C Gallo, S Lastoria, et al.
The Lancet. Microbe
|
January 30, 2026
Artesunate-pyronaridine-atovaquone-proguanil and artesunate-fosmidomycin-clindamycin compared with standard artesunate-pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana
Jean Claude Dejon Agobé, Oumou Maïga-Ascofaré, Ayôla Akim Adegnika, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 6, 2019
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial
Francesco Perrone, Michelino De Laurentiis, Sabino De Placido, et al.
Malaria Journal
|
May 20, 2021
A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria
Yeka Adoke, Rella Zoleko-Manego, Serge Ouoba, et al.
ESMO Open
|
March 4, 2026
Prognostic impact of pathological complete response and response-adapted outcomes in patients with gastroesophageal adenocarcinoma treated with neoadjuvant or perioperative treatments: a multicentric cohort study
M Airoldi, A Cammarota, J A Carbonell-Asins, et al.
Mbio
|
June 25, 2015
Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids
Visesato Mor, Antonella Rella, Amir M Farnoud, et al.
Page
of 49
Search research articles
Search
Showing results (471-480 of 488) with videos related to
Sort By:
Page
of 49
Plos Medicine
|
September 24, 2014
Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial
Raquel González, Ghyslain Mombo-Ngoma, Smaïla Ouédraogo, et al.
Antimicrobial Agents and Chemotherapy
|
June 12, 2026
Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV
Linda Stöger, Johannes Mischlinger, Tacilta Nhampossa, et al.
Science Advances
|
January 15, 2025
CD4<sup>+</sup>FOXP3Exon2<sup>+</sup> regulatory T cell frequency predicts breast cancer prognosis and survival
Clorinda Fusco, Francesca Di Rella, Antonietta Liotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial
F Perrone, F Nuzzo, F Di Rella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2012
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study
F Nuzzo, C Gallo, S Lastoria, et al.
The Lancet. Microbe
|
January 30, 2026
Artesunate-pyronaridine-atovaquone-proguanil and artesunate-fosmidomycin-clindamycin compared with standard artesunate-pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana
Jean Claude Dejon Agobé, Oumou Maïga-Ascofaré, Ayôla Akim Adegnika, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 6, 2019
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial
Francesco Perrone, Michelino De Laurentiis, Sabino De Placido, et al.
Malaria Journal
|
May 20, 2021
A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria
Yeka Adoke, Rella Zoleko-Manego, Serge Ouoba, et al.
ESMO Open
|
March 4, 2026
Prognostic impact of pathological complete response and response-adapted outcomes in patients with gastroesophageal adenocarcinoma treated with neoadjuvant or perioperative treatments: a multicentric cohort study
M Airoldi, A Cammarota, J A Carbonell-Asins, et al.
Mbio
|
June 25, 2015
Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids
Visesato Mor, Antonella Rella, Amir M Farnoud, et al.
Page
of 49